{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T20:25:56Z","timestamp":1748550356477},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jmmc-online.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.yjmcc.2016.02.015","type":"journal-article","created":{"date-parts":[[2016,2,20]],"date-time":"2016-02-20T02:54:24Z","timestamp":1455936864000},"page":"12-17","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Expressing an inhibitor of PLC\u03b21b sustains contractile function following pressure overload"],"prefix":"10.1016","volume":"93","author":[{"given":"David R.","family":"Grubb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Kiriazis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie R.","family":"McMullen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Jun","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Woodcock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2016.02.015_bb0005","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/415227a","article-title":"The failing heart","volume":"415","author":"Towbin","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0010","article-title":"The war against heart failure: the Lancet lecture","author":"Braunwald","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.yjmcc.2014.02.015","article-title":"Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs","volume":"70","author":"Schuetze","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0020","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00109-015-1314-y","article-title":"Cardiac fibroblasts: from development to heart failure","volume":"93","author":"Moore-Morris","year":"2015","journal-title":"J Mol Med-JMM."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0025","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2174\/138161282104141204124129","article-title":"Targeting cardiomyocyte Ca2+ homeostasis in heart failure","volume":"21","author":"Roe","year":"2015","journal-title":"Curr Pharm Design."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0030","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1161\/CIRCRESAHA.116.304937","article-title":"Mechanotransduction in cardiac hypertrophy and failure","volume":"116","author":"Lyon","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0035","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","article-title":"Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets","volume":"89","author":"Tham","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2013.12.018","article-title":"Cardiac SERCA2A\/B: therapeutic targets for heart failure","volume":"724","author":"Shareef","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0045","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/CIRCRESAHA.113.301651","article-title":"Mechanisms of altered Ca2+ handling in heart failure","volume":"113","author":"Luo","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0050","first-page":"2425","article-title":"Alterations in ryanodine receptors and related proteins in heart failure","volume":"2013","author":"Ather","year":"1832","journal-title":"Biochim Biophys Acta-Molecular Basis of Disease."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0055","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1006\/jmcc.2000.1343","article-title":"Ryanodine receptors\/calcium release channels in heart failure and sudden cardiac death","volume":"33","author":"Marks","year":"2001","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0060","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/CIRCRESAHA.109.210740","article-title":"Targeting sarcoplasmic reticulum Ca2+ uptake to improve heart failure: hit or miss","volume":"106","author":"Sipido","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0065","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.yjmcc.2014.10.005","article-title":"Phospholamban interactome in cardiac contractility and survival: a new vision of an old friend","volume":"77","author":"Haghighi","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0070","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1172\/JCI62834","article-title":"Calcium cycling proteins and heart failure: mechanisms and therapeutics","volume":"123","author":"Marks","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0075","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.yjmcc.2009.08.020","article-title":"Selective activation of the \u201cb\u201d splice variant of phospholipase C\u03b21 in chronically dilated human and mouse atria","volume":"47","author":"Woodcock","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0080","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.yjmcc.2015.04.016","article-title":"The atypical \u2018b\u2019 splice variant of phospholipase C\u03b21 promotes cardiac contractile dysfunction","volume":"84","author":"Grubb","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0085","first-page":"11","article-title":"Novel therapeutic targets in heart failure: the phospholipase C\u03b21b\u2013Shank3 interface","volume":"7","author":"Woodcock","year":"2015","journal-title":"Clinical Med Insights: Therapeutics."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0090","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/1043-2760(95)92522-K","article-title":"Regulation of phospholipase C\u03b2 isozymes by G-proteins","volume":"5","author":"Bristol","year":"1994","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0095","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1096\/fj.09-133983","article-title":"Gq-initiated cardiomyocyte hypertrophy is mediated by phospholipase C\u03b21b","volume":"23","author":"Filtz","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0100","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1096\/fj.07-102558","article-title":"The extreme C-terminal region of phospholipase C\u03b21 determines subcellular localization and function; the \u201cb\u201d splice variant mediates \u03b11-adrenergic receptor responses in cardiomyocytes","volume":"22","author":"Grubb","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0105","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.bbrc.2015.04.060","article-title":"Phospholipase C\u03b21b directly binds the SH3 domain of Shank3 for targeting and activation in cardiomyocytes","volume":"461","author":"Grubb","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0110","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1096\/fj.10-171470","article-title":"Phospholipase C\u03b21b associates with a Shank3 complex at the cardiac sarcolemma","volume":"25","author":"Grubb","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0115","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nm1085","article-title":"Systemic delivery of genes to striated muscles using adeno-associated viral vectors","volume":"10","author":"Gregorevic","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0120","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1172\/JCI61134","article-title":"Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease","volume":"122","author":"Sheikh","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0125","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1161\/CIRCHEARTFAILURE.112.972158","article-title":"No contribution of IP3-R(2) to disease phenotype in models of dilated cardiomyopathy or pressure overload hypertrophy","volume":"6","author":"Cooley","year":"2013","journal-title":"Circ Heart failure."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0130","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/01.CIR.101.1.71","article-title":"\u03b22-adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis","volume":"101","author":"Du","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0140","doi-asserted-by":"crossref","first-page":"H1079","DOI":"10.1152\/ajpheart.2000.279.3.H1079","article-title":"Adverse effects of constitutively active \u03b11B-adrenergic receptors after pressure overload in mouse hearts","volume":"279","author":"Wang","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0145","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm1000","article-title":"PKC\u03b1 regulates cardiac contractility and propensity toward heart failure","volume":"10","author":"Braz","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0150","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.yjmcc.2010.10.004","article-title":"Protein kinase C\u03b1 as a heart failure therapeutic target","volume":"51","author":"Liu","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0155","doi-asserted-by":"crossref","first-page":"H3768","DOI":"10.1152\/ajpheart.00486.2007","article-title":"Inducible and myocyte-specific inhibition of PKC\u03b1 enhances cardiac contractility and protects against infarction-induced heart failure","volume":"293","author":"Hambleton","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0160","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/CIRCULATIONAHA.105.592550","article-title":"Pharmacological- and gene therapy-based inhibition of protein kinase C\u03b1\/\u03b2 enhances cardiac contractility and attenuates heart failure","volume":"114","author":"Hambleton","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0165","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1161\/01.RES.0000105087.79373.17","article-title":"Protein kinase C\u03b1 negatively regulates systolic and diastolic function in pathological hypertrophy","volume":"93","author":"Hahn","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0170","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nm1101-1236","article-title":"Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of G\u03b1q\/G\u03b111 in cardiomyocytes","volume":"7","author":"Wettschureck","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0175","first-page":"65","article-title":"Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress","volume":"50","author":"Esposito","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0180","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1126\/science.280.5363.574","article-title":"Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy","volume":"280","author":"Akhter","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0185","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1050-1738(99)00004-3","article-title":"Gq signaling in cardiac adaptation and maladaptation","volume":"9","author":"Dorn","year":"1999","journal-title":"Trends Cardiovasc Med."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0190","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1161\/01.RES.0000150366.08972.7f","article-title":"Physiological growth synergizes with pathological genes in experimental cardiomyopathy","volume":"95","author":"Syed","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0195","doi-asserted-by":"crossref","first-page":"12407","DOI":"10.1074\/jbc.M110.191783","article-title":"Direct activation of human phospholipase C by its well known inhibitor U73122","volume":"286","author":"Klein","year":"2011","journal-title":"J Biol Chem."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0200","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1042\/bj3240645","article-title":"Phospholipase C inhibitor, U73122, releases intracellular Ca2+, potentiates Ins(1,4,5)P3-mediated Ca2+ release and directly activates inn channels in mouse pancreatic acinar cells","volume":"324","author":"Mogami","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0205","first-page":"257","article-title":"Inhibition of phosphoinositide phospholipase C by compounds U-83122 and D-609","volume":"2","author":"Powis","year":"1991","journal-title":"J Cell Pharmacol."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0210","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1126\/science.2541501","article-title":"Studies of inositol phospholipid-specific phospholipase C","volume":"244","author":"Rhee","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0215","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/mol.113.087403","article-title":"Structural insights into phospholipase C\u03b2 function","volume":"84","author":"Lyon","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0220","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1074\/jbc.M806994200","article-title":"Epac and phospholipase C\u03b5 regulate Ca2+ release in the heart by activation of protein kinase C\u03b5 and calcium-calmodulin kinase II","volume":"284","author":"Oestreich","year":"2009","journal-title":"J Biol Chem."},{"issue":"Pt 11","key":"10.1016\/j.yjmcc.2016.02.015_bb0225","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1242\/jcs.113.11.1851","article-title":"The Shank family of scaffold proteins","volume":"113","author":"Sheng","year":"2000","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.yjmcc.2016.02.015_bb0230","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/978-94-007-2888-2_28","article-title":"The biology of protein kinase C","volume":"740","author":"Zeng","year":"2012","journal-title":"Adv. Exp. Med. Biol."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282816300438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282816300438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T18:09:06Z","timestamp":1654366146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282816300438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":46,"alternative-id":["S0022282816300438"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2016.02.015","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expressing an inhibitor of PLC\u03b21b sustains contractile function following pressure overload","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2016.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}